Metabolic syndrome (MS), which includes a number of systemic clinical and biochemical processes (insulin resistance, abdominal obesity, dyslipidemia, arterial hypertension), attracts close attention of general practitioners. The risk factors and pathological processes leading to the development of this syndrome remain controversial. Several hypotheses for the development of MS have been proposed, of which the theory of insulin resistance is the leading one. To date, all possible causes and mechanisms for the development of MS have not been finally disclosed. Non-esterified fatty acids play an important role in the development of MS.

metabolic syndrome, insulin resistance, fatty acids, blood, glucose

Alexandrov O.V. Alekhina R.M. et al. Metabolic syndrome, etiology and pathogenesis // Ross.med. magazine-2016-№6-pp.50-55

Carcaillon L, Brailly-Tabard S High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women.//Neurology. 2018 Feb 11;82(6):504-11.

Metabolic syndrome. Report of the National Heart, Lung and Blood Institute of the American Heart Association // Clinical Pharmacology and Therapy -2019-No. 13-pp.66-68

Titov V.N. Atherosclerosis as a pathology of polyunsaturated fatty acids. Biological foundations of the theory of atherosclerosis-M.2018

Titov V.N. Combined disorders of essential fatty acids and endothelium-dependent vasodilation in the pathogenesis of arterial hypertension and atherosclerosis //Clin. laboratory diagnostics -2018-№10-pp.3-13

Titov V.N. The unity of the physicochemical and biological action of glycerol and cholesterol alcohols in the absorption of fatty acids by cells. Features of the pathogenesis of "metabolic pandemics" // Klin and lab diagnostics -2015.- No. 1.-pp.23-28.

Endakova E.A. Novgorodtseva T.P. Modification of the composition of blood fatty acids in cardiovascular diseases - Vladivostok, 2017.